Diagnostics stocks were trading lower on June 23 after Amazon India launched home diagnostics services in 6 cities through app.
At 9:40 am on June 23, Stocks like Dr Lal PathLabs and Metropolis Healthcare fell over 2% to trade at Rs 2,841 and Rs 1,687, respectively.
Other diagnostics stocks were also trading lower with Krsnaa Diagnostics' scrip trading 1.3% lower on NSE while Thyrocare Technologies' counter was trading nearly 1% lower at Rs 1,000.2. Shares of Suraksha Diagnostic were trading 0.52% lower at Rs 332 apiece.
Amazon India on Sunday announced the launch of Amazon Diagnostics, an at-home service for customers to book lab tests, schedule and track appointments, and access digital reports through the Amazon app.
The service, being offered in collaboration with Orange Health Labs, will be available in Bengaluru, Delhi, Gurgaon, Noida, Mumbai, and Hyderabad, across over 450 PIN codes, the company said in a statement.
With this addition, Amazon has now integrated its existing pharmacy and clinic services under Amazon Medical.
"This expansion strengthens the foundation of Amazon Medical by building on the existing service of Pharmacy and Clinic. With Amazon Pharmacy, customers get access to a wide range of prescription medications and healthcare essentials, along with a free telemedicine consultation service and delivery benefits for Prime and non-Prime members. Amazon Clinic enables customers to consult licensed doctors for a range of primary healthcare needs through a seamless digital experience," Amazon said.
Amazon Diagnostics will offer over 800 diagnostic tests and doorstep sample collection within 60 minutes.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
